1. Home
  2. BV vs ALVO Comparison

BV vs ALVO Comparison

Compare BV & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

N/A

Current Price

$12.14

Market Cap

1.0B

ML Signal

N/A

Logo Alvotech

ALVO

Alvotech

N/A

Current Price

$4.50

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BV
ALVO
Founded
1939
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BV
ALVO
Price
$12.14
$4.50
Analyst Decision
Buy
Buy
Analyst Count
11
6
Target Price
★ $15.35
$7.20
AVG Volume (30 Days)
813.3K
★ 907.7K
Earning Date
11-10-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$3.21
$10.83
Revenue Next Year
$0.18
$20.41
P/E Ratio
★ N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$2.94
52 Week High
$15.00
$6.53

Technical Indicators

Market Signals
Indicator
BV
ALVO
Relative Strength Index (RSI) 75.26 36.63
Support Level $11.47 $3.10
Resistance Level $12.59 $4.59
Average True Range (ATR) 0.33 0.24
MACD 0.19 -0.07
Stochastic Oscillator 92.68 5.71

Price Performance

Historical Comparison
BV
ALVO

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: